Semin intervent Radiol 2011; 28(3): 325-332
DOI: 10.1055/s-0031-1284459
© Thieme Medical Publishers

Balloon-occluded Retrograde Transvenous Obliteration (BRTO): Follow-Up and Postprocedural Imaging

Brian G. Sauer1 , Saher S. Sabri2 , Vanessa M. Shami1 , Abdullah M. S. Al-Osaimi1
  • 1Division of Gastroenterology and Hepatology, Department of Medicine, University of Virginia Health System, Charlottesville, Virginia
  • 2Division of Vascular Interventional Radiology, Department of Radiology, University of Virginia Health System, Charlottesville, Virginia
Further Information

Publication History

Publication Date:
15 August 2011 (online)

Preview

ABSTRACT

The majority of patients undergoing balloon retrograde transvenous obliteration (BRTO) are decompensated cirrhotic for either bleeding gastric varices (GV) or hepatic encephalopathy. These patients will require close follow-up and assessments pre- and post-BRTO including clinical, laboratory, endoscopic, and imaging evaluations. It is essential that clinicians are aware of the potential benefits and complications that may result from BRTO. These complications may include fever, chest or epigastric pain, hemoglobinuria, transient hypertension, nausea or vomiting, and many more. These complications usually resolve within the first 10 days. Laboratory abnormalities are transient and uncommon. Radiologic and endoscopic follow-up are required including computed tomography (CT), magnetic resonance imaging (MRI), routine upper endoscopy and endoscopic ultrasound (EUS), which are detailed in this review. Patients undergoing BRTO are usually complicated and will require a team approach. This team should include the hepatologist, endoscopist, and interventional radiologist. Understanding and open dialogue are essential in the management of post-BRTO patients. The authors review the possible benefits, potential complications, and the evaluation tools needed to improve outcomes.

REFERENCES

Abdullah M. S. Al-OsaimiM.D. F.A.C.P. F.A.C.G. A.G.A.F. 

Associate Professor of Medicine and Surgery, Medical Director of Liver Transplantation, Division of Gastroenterology and Hepatology, Department of Medicine, University of Virginia Health System

Box 800708, 1215 Lee Street, Charlottesville, VA 22908

Email: aa6h@virginia.edu